Breaking
Neuralink Enrolls 21 Trial Participants in Human Implant Study
Elon Musk's brain-computer interface company has now implanted 21 people with its neural device, marking a significant acceleration in its clinical trial timeline.
2 articles
Elon Musk's brain-computer interface company has now implanted 21 people with its neural device, marking a significant acceleration in its clinical trial timeline.
Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.